Medscape at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Medscape takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8072. Its program centres on bringing newer treatments into practice, from first-line and early breast cancer to targeted drugs for ovarian cancer that no longer responds to platinum chemotherapy. It also covers choosing therapy in metastatic hormone-sensitive and non-metastatic castration-resistant prostate cancer.

OrganizationESMO 2026 Attendance
Medical education & publishingExhibitor
WebMD's medical news and continuing-education service for physicians and other clinicians.
Booth
Exhibiting at Booth 8072
Satellite
Fri Oct 23
09:45–11:15
Satellite
Sat Oct 24
18:30–20:00
Satellite
Sun Oct 25
13:00–14:30
Medscape Global Oncology - Navigating the New Era of mHSPC and nmCRPC: Data-Driven Strategies for Therapy Selection
Sponsored session · with University Medical Center Freiburg
Genitourinary cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Medscape

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction